PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

American Made, Cheaper Abroad: Pataday

Pataday in its American packaging

A weekly series identifying prescription drugs manufactured in America and their prices.

Pataday (olopatadine hydrochloride ophthalmic solution) is a solution used for the treatment of itchy or watering eyes caused by allergies. Pataday is manufactured in the U.S., but that doesn’t mean that’s where it’s cheapest for Americans. In fact, you can save 79% by ordering it from a verified foreign online pharmacy: one 2.5 ml vial of Pataday costs $161 at a Walgreens in New York City, but only $34 from a PharmacyChecker.com-approved pharmacy.

Share
Tagged with: , ,

CVS Disregarding Patient Privacy in New Program

Our friends at RxRights have chastised CVS’s new ExtraCare Pharmacy & Health Rewards program because its participants must sign a HIIPA waiver. HIIPA, the Health Insurance Portability and Accountability Act, is the federal law that protects customers’ health information. RxRights is concerned that CVS will share its prescription sales data with pharmaceutical companies, assisting them in use direct to consumer marketing that can lead to higher medicine costs.

Check out the full blog post on RxRights.org.

Share

Obamacare Out-of-Pocket Cost Delays A Bad Prescription for Consumers

Americans with high out-of-pocket healthcare costs will be disappointed with a new Affordable Care Act (Obamacare) delay announced by the Obama administration. The delay allows insurers and employers using more than one benefits administrator to wait one extra year – until 2015 – before being required to limit out-of-pocket costs to a maximum of $6,350 for an individual or $12,700 for a family, as mandated by the law. Instead, they will be permitted to maintain separate out-of-pocket limits for various benefits. For example, a patient may have a $6,350 cap for doctor visits and another $6,350 cap for prescription drugs.

Except that there may actually be no cap at all for prescription drug plans. Plans currently without out-of-pocket caps will not be subject to mandatory ones in 2014.

The only reason for the delay mentioned in a recent New York Times article is a technological problem. Many companies use different administrators for different benefits, and their computer systems are currently unable to combine all costs from different programs for a given patient. As the New York Times says, “In many cases, the companies have separate computer systems that cannot communicate with one another.” Companies need more time to upgrade their software to accommodate this.

Obamacare was passed in 2010, and the mandatory out-of-pocket limits were slated to go into effect in 2014, giving companies four years to figure out how to get their computers to talk to each other.

This does not seem like a legitimate reason to delay prescription drug spending caps. Fifty million adults did not fill a prescription last year due to cost; access to affordable medicine is a big problem in the United States, and failure to implement out-of-pocket spending limits will likely keep prescriptions unfilled.

Fortunately, safe international pharmacies offer low prices to Americans. As of last November, prices for brand name medication were 85% less expensive from them when compared to U.S. pharmacies. If you choose to order medication from abroad, make sure the pharmacy is a PharmacyChecker.com verified online pharmacy.

Share

American Made, Cheaper Abroad: Janumet

Janumet, manufactured in the USA weekly series identifying prescription drugs manufactured in America and their prices.

Janumet (Sitagliptin Metformin HCL) is a popular prescription drug that combines two different diabetes medications, Januvia (sitagliptin) and metformin. Janumet is only for individuals with type II diabetes. It is manufactured by Patheon in the U.S., and is marketed by Merck. Despite being made in the U.S., the price for Janumet is much lower for Americans who choose to order it from a verified international online pharmacy rather than a U.S. pharmacy. From the former, 180 pills of Janumet 50/500 mg costs $172. From the latter, the same quantity costs a staggering $1,050. That’s a 83% savings, or $3,512 over the course of one year.

Find a verified international online pharmacy today.

Share
Tagged with: , , , ,

American Made, Cheaper Abroad: Strattera

 

Strattera, manufactured in the U.S.A weekly series identifying prescription drugs manufactured in America and their prices.

 Strattera (Atomoxetine HCl) is a popular attention deficit hyperactivity disorder medication for use by children and adults. Strattera, an Eli Lilly product, is manufactured right here in the U.S.A., but is far more expensive in American pharmacies than elsewhere. In fact, the price difference is shocking – 90 capsules (25 mg) will run you $828 at a Rite-Aid in New York City; from a verified international pharmacy it only costs $310.50. That’s a 63% savings, or just under $2,100 over the course of a year.

 Check back next week for the savings on another American drug available abroad.

                                           

Share
Tagged with: , , ,

Pennsylvania Seniors Skipping Meals, Meds, or Both According to New Study

Seniors are continuing to skip meals or leave prescriptions unfilled due to budgetary constraints, according to a survey conducted by Public Health Management Corporation’s Center for Data Innovation (PHMC). PMHC surveyed 10,000 households in Southeastern Pennsylvania, and found that 112,500 older adults (60 +) in the region skipped a meal or didn’t fill a prescription because of tight budgets. The study points out that skipping either medication or a meal often leads to negative health outcomes. Many of the older adults skipping either had a chronic condition; 81% had arthritis, 67% had high blood pressure, and 50% had diabetes.

Read the results of the survey here.

Share